We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Timing is everything

28 July 2005 By Robert Cyran

Chief executive Tom McKillop couldn t pick a better time to leave the AngloSwedish drug company. Sales and earnings are soaring. But he bequeaths his successor a challenge: fixing the group s sputtering drug pipeline.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)